Log In
BCIQ
Print this Print this
 

Ionic Contra Viral Therapy (ICVT) (CLS003)

  Manage Alerts
Collapse Summary General Information
Company Maruho Co. Ltd.
DescriptionTopical formulation of furosemide and digoxin
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationDermal ulcers
Indication DetailsTreat non-genital warts caused by Human papillomavirus (HPV)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/20/2012

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today